Key result
In patients with STEMI treated with manual thrombus aspiration, ischemic postconditioning did not reduce infarct size compared to control.
Why the study?
Does ischemic postconditioning reduce infarct size in patients with STEMI treated with manual thrombus aspiration?
RCT (n=87)
randomized
Does ischemic postconditioning reduce infarct size in patients with STEMI treated with manual thrombus aspiration?
Ischemic postconditioning after routine manual thrombus aspiration offers no benefit in reducing infarct size or improving clinical outcomes in STEMI patients.
Answers are grounded in this paper and cite their sources.
Ischemic postconditioning adds no value after thrombus aspiration in STEMI; confirms futility and should not be pursued.
OBJECTIVES: The underutilization of manual thrombus aspiration (MTA) may have reduced the benefits of ischemic postconditioning (PostCon), as it reduces thrombus embolization. We aimed to assess the benefits of PostCon in patients with ST-segment elevation myocardial infarction (STEMI) after the systematic utilization of MTA. METHODS: A total of 87 patients were enrolled in a prospective, randomized trial (43 PostCon and 44 controls). After MTA, PostCon was performed on the treatment group by applying 4 cycles of alternate reperfusion and reocclusion (60 seconds each) using the angioplasty balloon. The primary end point was infarct size assessed by the area under the curve (AUC) of troponin T (TnT) activity. The secondary end points were left ventricle ejection fraction (LVEF) and major cardiac events (new myocardial infarction or cardiac death) both at discharge and at follow-up. RESULTS: The AUC for TnT was no different with respect to study arms (median [interquartile range]): PostCon = 8.9 (10.6) versus control = 8.2 (10.6), P = .68. Left ventricle ejection fraction improved from in-hospital to follow-up (9 ± 3 months) for the entire cohort (46.3% ± 7.3% vs 52.2% ± 10.7%, P < .001), with no differences between PostCon and controls (51.6% ± 9.5% vs 52.7% ± 11.9%, P = .89); major cardiac events at 14 ± 4 months of follow-up were also no different (PostCon = 1.0 (2.3%) vs control = 0, P = .49). CONCLUSION: In patients with STEMI treated with MTA, PostCon offered no benefits to infarct size, LVEF, or major cardiac events.
No takes yet. Share an insight, caveat, or question.
Luz et al. (2015) conducted an RCT in ST-segment elevation myocardial infarction (STEMI) (n=87). Ischemic postconditioning vs. Control (manual thrombus aspiration only) was evaluated on Infarct size assessed by the area under the curve (AUC) of troponin T (TnT) activity (p=0.68). In patients with STEMI treated with manual thrombus aspiration, ischemic postconditioning did not reduce infarct size compared to control.
Synapse has enriched 10 related papers. Consider them for comparative context: